TMCnet News
Eitan Medical Receives FDA Clearance for Upgraded Sapphire™ Infusion Pump SystemNETANYA, Israel, Jan. 19, 2021 /PRNewswire/ -- Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that its upgraded Sapphire™ infusion pump system software Rev15, which includes the infusion pump, administration sets and accessories, has received US Food and Drug Administration (FDA) 510(k) clearance. The Sapphire™ infusion system is the company's flagship infusion device, and is used across the U.S. within alternate sites, homecare markets, emergency medical services (EMS) and hospitals. The compact and robust Sapphire™ infusion pump is designed to deliver a wide range of therapies for varied clinical uses, such as saline, Total Parenteral Nutrition (TPN), lipids, IV medication, perineural medication, epidural medication, blood, and blood products, making it suited for complex and demanding medical scenarios. The pump's smart technology includes a unique full color touch screen for intuitive and fast operation, built in safety mechanisms aimed to enhance patient safety, and advanced technology that helps minimize dosage errors and false alarms. The most recent hardware and software upgrade adds a number of key improvements, utilizing the Sapphire™ family's future-ready features. The new device features include:
About Eitan Medical Eitan Medical is reimagining drug delivery, with reliable innovations that put patients at the center of care, making drug delivery easier and safer than ever before. Patient safety and care is only the starting point, as Eitan Medical goes beyond - delivering connected, intuitive drug delivery and infusion solutions that are designed to improve patient and clinician quality of life across the continuum of care, including hospital, ambulatory, and home care environments. For over a decade, Eitan Medical has provided safe, intuitive, and flexible solutions that meet evolving drug delivery needs. Eitan Medical's product lines include the Sapphire™ infusion platform**, providing connected infusion therapy systems in hospital and ambulatory settings; the Sorrel™ wearable drug delivery platform***, the patient-centric on-body injector for delivery of biologic treatments; and Avoset™****, connected infusion systems for the home care market. * NRFit® is a trademark of B. Braun ** Q Core Medical Ltd is legal manufacturer of the Sapphire™ infusion pump *** Sorrel Medical Ltd is legal manufacturer of the Sorrel™ wearable drug delivery platform (FDA investigational device) **** The Avoset™ devices are under development Eitan Medical, Sapphire, Avoset, and Sorrel are trademarks or registered trademarks of Eitan Medical. Media Relations Contact:
View original content:http://www.prnewswire.com/news-releases/eitan-medical-receives-fda-clearance-for-upgraded-sapphire-infusion-pump-system-301210805.html SOURCE Eitan Medical |